[go: up one dir, main page]

LV12658B - Sausa aktivas vielas pulvera ievadisanas panemiens plausas - Google Patents

Sausa aktivas vielas pulvera ievadisanas panemiens plausas

Info

Publication number
LV12658B
LV12658B LV010041A LV010041A LV12658B LV 12658 B LV12658 B LV 12658B LV 010041 A LV010041 A LV 010041A LV 010041 A LV010041 A LV 010041A LV 12658 B LV12658 B LV 12658B
Authority
LV
Latvia
Prior art keywords
pancake
powders
active substance
powder injection
substance powder
Prior art date
Application number
LV010041A
Other languages
English (en)
Other versions
LV12658A (lv
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of LV12658A publication Critical patent/LV12658A/lv
Publication of LV12658B publication Critical patent/LV12658B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
LV010041A 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas LV12658B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
LV12658A LV12658A (lv) 2001-05-20
LV12658B true LV12658B (lv) 2001-09-20

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
LV010041A LV12658B (lv) 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas

Country Status (44)

Country Link
EP (1) EP1117442A1 (lv)
JP (1) JP2002524535A (lv)
KR (1) KR20010075063A (lv)
CN (1) CN1317977A (lv)
AP (1) AP1374A (lv)
AR (1) AR022090A1 (lv)
AU (1) AU753014B2 (lv)
BG (1) BG105430A (lv)
BR (1) BR9913722A (lv)
CA (1) CA2343920A1 (lv)
CO (1) CO5130023A1 (lv)
CZ (1) CZ2001829A3 (lv)
DZ (1) DZ2892A1 (lv)
EA (1) EA003476B1 (lv)
EE (1) EE200100151A (lv)
GE (1) GEP20043257B (lv)
GT (1) GT199900156A (lv)
HK (1) HK1042231A1 (lv)
HN (1) HN1999000159A (lv)
HR (1) HRP20010189A2 (lv)
HU (1) HUP0103837A3 (lv)
ID (1) ID28845A (lv)
IL (2) IL141562A0 (lv)
IS (1) IS5878A (lv)
LT (1) LT4897B (lv)
LV (1) LV12658B (lv)
MA (1) MA25590A1 (lv)
MY (1) MY129282A (lv)
NO (1) NO20011251L (lv)
NZ (1) NZ510168A (lv)
OA (1) OA11781A (lv)
PA (1) PA8481901A1 (lv)
PE (1) PE20001061A1 (lv)
PL (1) PL195574B1 (lv)
SA (1) SA99200718B1 (lv)
SK (1) SK3442001A3 (lv)
TN (1) TNSN99173A1 (lv)
TR (1) TR200101182T2 (lv)
TW (1) TWI226248B (lv)
UA (1) UA76085C2 (lv)
UY (1) UY25711A1 (lv)
WO (1) WO2000015262A1 (lv)
YU (1) YU24201A (lv)
ZA (1) ZA200101995B (lv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
WO2000075281A2 (en) 1999-06-09 2000-12-14 University Technology Corporation Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
WO2003043585A2 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
JP2005518453A (ja) 2002-02-25 2005-06-23 ディフュージョン・ファーマシューティカルズ・エルエルシー 二極性トランスカロテノイド塩およびそれらの使用
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
KR101725225B1 (ko) 2004-04-23 2017-04-12 사이덱스 파마슈티칼스, 인크. 술포알킬 에테르 시클로덱스트린 함유 dpi 제형
EP1853544A4 (en) * 2005-02-24 2010-06-16 Diffusion Pharmaceuticals Llc TRANSCAROTENOIDS AND THEIR SYNTHESIS, THEIR PREPARATION AND USES THEREOF
JPWO2006095788A1 (ja) * 2005-03-09 2008-08-14 小野薬品工業株式会社 粒子およびその粒子を含有する製剤
HUE035181T2 (hu) 2005-10-26 2018-05-02 Cydex Pharmaceuticals Inc Szulfoalkil-éter-ciklodextrin kompozíciók és eljárások elõállításukra
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
EA200970944A1 (ru) 2007-04-13 2010-06-30 Диффьюжн Фармасьютикалз Ллс Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
JP2011502125A (ja) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー 小分子拡散を促進する新しい種類の治療法
DK2432502T3 (en) 2009-05-20 2018-03-12 Aeras STABLE, SPRAY DRIED, IMMUNOGENE, VIRUS COMPOSITIONS
CN108464976A (zh) 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
ES2911116T3 (es) 2012-05-03 2022-05-17 Janssen Sciences Ireland Unlimited Co Formulaciones de ácido poliinosínico-policitidílico (poli (I:C)) para el tratamiento de infecciones de las vías respiratorias altas
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
KR102489034B1 (ko) 2016-03-24 2023-01-13 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
DE69332240T2 (de) * 1992-06-12 2003-04-10 Teijin Ltd., Osaka Ultrafeines pulver zur inhalation und dessen herstellung
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
ES2236832T3 (es) * 1997-01-16 2005-07-16 Massachusetts Institute Of Technology Preparacion de particulas para inhalacion.
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
MY129282A (en) 2007-03-30
CZ2001829A3 (cs) 2001-09-12
GEP20043257B (en) 2004-06-25
SK3442001A3 (en) 2001-11-06
TWI226248B (en) 2005-01-11
UA76085C2 (en) 2006-07-17
LT2001021A (en) 2001-11-26
TR200101182T2 (tr) 2001-09-21
BR9913722A (pt) 2001-05-29
KR20010075063A (ko) 2001-08-09
PL195574B1 (pl) 2007-10-31
IL141562A0 (en) 2002-03-10
NO20011251D0 (no) 2001-03-13
NO20011251L (no) 2001-04-17
AU753014B2 (en) 2002-10-03
ZA200101995B (en) 2002-03-11
SA99200718B1 (ar) 2006-11-04
NZ510168A (en) 2003-09-26
PA8481901A1 (es) 2002-04-25
GT199900156A (es) 2001-03-07
AP1374A (en) 2005-02-28
TNSN99173A1 (fr) 2005-11-10
LV12658A (lv) 2001-05-20
ID28845A (id) 2001-07-05
PL346768A1 (en) 2002-02-25
IL141562A (en) 2007-07-24
JP2002524535A (ja) 2002-08-06
HUP0103837A2 (hu) 2002-05-29
HRP20010189A2 (en) 2005-04-30
HUP0103837A3 (en) 2002-11-28
EE200100151A (et) 2002-06-17
CN1317977A (zh) 2001-10-17
YU24201A (sh) 2003-08-29
HN1999000159A (es) 1999-11-11
DZ2892A1 (fr) 2003-12-15
EP1117442A1 (en) 2001-07-25
EA200100300A1 (ru) 2001-10-22
AP2001002093A0 (en) 2001-03-31
WO2000015262A1 (en) 2000-03-23
IS5878A (is) 2001-03-05
CA2343920A1 (en) 2000-03-23
LT4897B (lt) 2002-02-25
EA003476B1 (ru) 2003-06-26
OA11781A (en) 2005-07-26
AR022090A1 (es) 2002-09-04
HK1042231A1 (zh) 2002-08-09
CO5130023A1 (es) 2002-02-27
BG105430A (en) 2001-12-29
AU6039799A (en) 2000-04-03
MA25590A1 (fr) 2002-12-31
PE20001061A1 (es) 2000-10-08
UY25711A1 (es) 1999-11-17

Similar Documents

Publication Publication Date Title
LV12658B (lv) Sausa aktivas vielas pulvera ievadisanas panemiens plausas
DE60035911D1 (de) Trockenpulverinhalator
HUP0001799A3 (en) Dry powder inhaler
IS4364A (is) Innöndunarbúnaður fyrir þurrduft
EP0927025A4 (en) DRY POWDER COMPOSITION WITH ACTIVE INGREDIENT ENCLOSED IN LIPOSOMES
EE200400122A (et) Pulberinhalaator
FI954098A7 (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
DE69428743D1 (de) Trockenpulverinhalator
FI962272L (fi) Kuivan jauhemaisen inhalaattorilääkkeen kantaja
FI951838A7 (fi) Kuivan jauheen sisäänhengityskone
ATE460955T1 (de) Trockenpulver-inhalator
NO994519L (no) Fremstilling av pulveragglomerater
DE60023254D1 (de) Kosmetische Kompaktpuder Zusammensetzung
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
DE69839356D1 (de) Trockenpulverinhalator für Kapseln
HUP0104483A3 (en) Fungicidal active substance combinations and use thereof
EP1065675A4 (en) FERROMAGNETIC POWDER
DE69926719D1 (de) Nickel-metallpulver
AU2001243611A1 (en) Stabilized dry powder formulations
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
GB9916316D0 (en) Dry powder compositions
ID18341A (id) Komposisi-komposisi keju berbubuk kering
ID23192A (id) Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol
GB9719093D0 (en) Improvements to dry powder inhalers
GB0003935D0 (en) Formulation for dry powder inhaler